A Prospective Study of Treating Duodenal Papillary Sphincter in Different Ways During ERCP

NCT ID: NCT03416205

Last Updated: 2018-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

450 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-20

Study Completion Date

2021-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Endoscopic retrograde cholangiopancreatography (ERCP) is commonly performed to remove bile duct stones.Endoscopic sphincterotomy (EST), endoscopic papillary balloon dilation (EPBD), and endoscopic sphincterotomy plus balloon dilation (sEST+EPBD) are 3 methods used to enlarge the papillary orifice, but their efficacy and safety remains controversial. This study aimed to compare these methods for treating common bile duct (CBD) stones.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigators first divided the patients with different sizes of common bile duct stones into two groups. The bile duct stone diameter of group A is less than 1.0cm while group B is more than 1.0cm and less than 1.5cm. Each group compared Endoscopic sphincterotomy (EST), endoscopic papillary balloon dilation (EPBD), and endoscopic sphincterotomy plus balloon dilation (sEST+EPBD) in ERCP. Through the postoperative comparison of relevant inspection test indicators, the recovery of patients, whether the occurrence of complications, including infection,bleeding,pancreatitis,perforation , and 1 year stone recurrence rate,Investigators assess the advantages and disadvantages in three different strategies in different sizes of common bile duct stones , and finally get a relatively objective evaluation to guide our daily ERCP work on the choice of duodenal papillary sphincter treatment strategy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ERCP

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EST

EST is an operation using the Erbao electric knife and Three-cavity incision knife to make a large incision to the duodenal nipples,and the incision scope is the nipple mouth uplift length of 4/5. It has been used since 1974. The technique is intuitive and intact. However, EST cut too small to achieve the purpose of treatment and will affect the next step, and if the incision is too large it may be easier to occur gastrointestinal perforation and bleeding.The EST will also damage the anatomy of the Oddi sphincter structure,which causes bacterial reflux to the bile duct, the recurrence of CBD.Some surgeons prefer it because it's postoperative pancreatitis rate is lower and it may be easier to find the lesion position if bleeding or perforation occurs.

Group Type EXPERIMENTAL

Erbao electric knife

Intervention Type DEVICE

Erbao electric knife is used to cut the Duodenal sphincter

Three-cavity incision knife

Intervention Type DEVICE

Three-cavity incision knife is used to cut the Duodenal sphincter

EPBD

EPBD is an operation using the Columnar expansion balloon to expand duodenal to achieve the purpose of using the basket and other instruments to take stone out. Balloon expansion may retain part of the sphincter not destroyed, and basically retain the normal physiological function of the nipple sphincter.Thus it may reduce the risk of recurrence of stones and bacterial reflux. However,the postoperative pancreatitis rate is high(4.8% -19.5% ), and nipple sphincter tear is uncontrollable in EPBD.If the digestive tract perforation or bleeding occur after EPBD,it is hard to accurately find the lesion position.Some surgeons prefer it for it's lower bleeding and perforation rate.

Group Type EXPERIMENTAL

Columnar expansion balloon

Intervention Type DEVICE

Columnar expansion balloon is used to expand the the Duodenal sphincter

sEST+EPBD

sEST+EPBD is an operation combining EST and EPBD. Investigators use the Erbao electric knife and Three-cavity incision knife to make a small incision to the duodenal nipples, and the incision length is less than 5mm while the incision scope is less than the nipple mouth uplift length of 1/2. Then, Investigators match the appropriate Columnar expansion balloon according to the diameter of the common bile duct and gradually expand the duodenal nipples.This method allows the nipple sphincter to be cut in a small range, then the balloon can guide the direction of the nipple sphincter tearing after the expansion , so that the digestive tract bleeding, perforation may be smaller and more controllable. Besides,it may reduce postoperative pancreatitis rate and the recurrence rate of stones.

Group Type EXPERIMENTAL

Erbao electric knife

Intervention Type DEVICE

Erbao electric knife is used to cut the Duodenal sphincter

Three-cavity incision knife

Intervention Type DEVICE

Three-cavity incision knife is used to cut the Duodenal sphincter

Columnar expansion balloon

Intervention Type DEVICE

Columnar expansion balloon is used to expand the the Duodenal sphincter

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erbao electric knife

Erbao electric knife is used to cut the Duodenal sphincter

Intervention Type DEVICE

Three-cavity incision knife

Three-cavity incision knife is used to cut the Duodenal sphincter

Intervention Type DEVICE

Columnar expansion balloon

Columnar expansion balloon is used to expand the the Duodenal sphincter

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 20-80 years old
* CT or MRCP diagnose the patients with Common bile duct stones
* The diameter of the stone is less than or equal to 1.5cm
* Patients with the indications for ERCP
* Patients and their families agree to participate in the trial

Exclusion Criteria

* Stones are too large (\> 1.5cm)
* A history of gastrointestinal surgery
* ERCP and EST or EPBD surgery history
* Patients generally poor, total bilirubin\> 200umol / L or PT time extension\> 3s
* Patients with mental illness or other serious heart and lung disease
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nanfang Hospital, Southern Medical University

OTHER

Sponsor Role collaborator

Zhujiang Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Changhui Yu, Doctor

Role: PRINCIPAL_INVESTIGATOR

Zhujiang Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhujiang Hospital

Guangzhou, Guangdong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-XHNK-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.